Pure Global: Malaysia-Thailand's MedTech Fast-Track, Hacking the New Reliance Sandbox

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Pure Global: Malaysia-Thailand's MedTech Fast-Track, Hacking the New Reliance Sandbox

Listen for free

View show details

About this listen

This week, we dive into the groundbreaking regulatory reliance program just announced between Malaysia and Thailand. This pilot program, running from February to April 2026, could fundamentally change the way medical devices are registered in the region, creating a new "fast-track" lane for market access. We explore what this "regulatory sandbox" means for the future of ASEAN MedTech integration. Imagine launching your new Class C diagnostic device in Southeast Asia. Previously, you faced two completely separate, 18-month review timelines for Malaysia and Thailand, doubling your costs and delaying patient access. This new pilot offers a potential pathway to cut that second registration time in half, but only if you perfectly navigate the new, untested submission requirements. One mistake in your dossier could lead to rejection from the very fast-track you were counting on. Key Takeaways This Episode: 1. What is the new Malaysia-Thailand regulatory reliance program and does my device qualify? 2. How can this pilot potentially cut my product's time-to-market in ASEAN? 3. What are the critical differences in the submission dossier for this reliance route versus a standard registration? 4. Is this pilot a true signal of a future pan-ASEAN single market for medical devices? 5. What are the hidden risks in this new "sandbox" program that could derail an application? 6. How should this news immediately change my company's ASEAN market entry strategy for 2026? 7. Which reference country approvals will give me the biggest advantage in this new program? Navigating the future of ASEAN's regulatory landscape requires both local expertise and strategic foresight. At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies, helping you turn regulatory shifts into market opportunities. From developing an efficient regulatory strategy to acting as your local representative, our technology-driven approach streamlines global market access. Contact us to learn how we can help you leverage this new Malaysia-Thailand program at info@pureglobal.com or visit us at https://pureglobal.com/.

No reviews yet